Loading clinical trials...
Loading clinical trials...
Growth Hormone Co-treatment With the Microflare Stimulation Protocol in IVF/ICSI, Can it be a New Hope for Poor Responders?
The effect of use of the microflare down regulation protocol on the outcome of the IVF/ICSI cycles in poor responders
The microflare as a method of down regulation protocol can be used to prepare the females suffering from poor ovarian reserve to undergo IVF/ICSI cycles. In this study we are trying to outline its effect on the clinical pregnancy rate as a main primary outcome, and to compare its use with the addition of growth hormone to the same protocol.
Age
20 - 45 years
Sex
FEMALE
Healthy Volunteers
No
Kasr el aini hospital
Cairo, Cairo Governorate, Egypt
Start Date
July 1, 2014
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
January 28, 2015
145
ACTUAL participants
Growth hormone (Norditropin, Novo nordisk)
DRUG
Lead Sponsor
Woman's Health University Hospital, Egypt
NCT01662466
NCT02179255
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01897324